Saxena Nishant C
High convictionChief Business Officer · Corbus Pharmaceuticals Holdings, Inc.
Every open-market stock purchase Saxena Nishant C has reported to the SEC on Form 4 that met our signal bar, parsed straight from the filings. Insiders sell for many reasons, but they buy with their own money for one — this page tracks where how the prices paid compare to where the stock trades now.
Where the buys stand today
- CRBPCorbus Pharmaceuticals Holdings, Inc.
One purchase totalling $25.0K at an average of $9.63 per share. See all insider buying in CRBP →
Avg price paid$9.63Latest price—Market capUnknown
All reported buys
Get alerted the next time Saxena Nishant C — or any insider — buys
We watch every Form 4 as it hits SEC EDGAR and alert you when insiders cluster into the same stock.
About this data
Figures are parsed from Saxena Nishant C's Form 4 filings on SEC EDGAR (CIK 2136365) and cover open-market purchases (transaction code P) — grants, option exercises, and sales are excluded, which is why totals here can differ from raw filing counts. Every row links to its source document.
This page is informational and reflects public filing data. It is not investment advice.